Printer Friendly

BIORELEASE CORP. FILES REGISTRATION STATEMENT WITH SEC FOR STOCK OFFERING OF 160,000 UNITS OF COMMON STOCK (800,000 SHARES) AND WARRANTS

 SALEM, N.H., March 23 /PRNewswire/ -- Biorelease Corp. (NASDAQ: BREL) today announced that it has filed a registration statement (on Form S1) with the Securities and Exchange Commission for a public offering by the company of up to 160,000 units, each consisting of five shares of common stock and three detachable, callable warrants.
 Biorelease Corp. is conducting pre-marketing activities on Erythrogen(tm) , its first cell-culture additive. The company is dedicated to developing pharmaceutical and biological applications of its hemoglobin-based and chondroitin sulfate-based carrier technologies. The company is headquartered in Salem, N.H.
 A registration statement relating to these securities has been filed with the Securities and Exchange Commission, but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
 -0- 3/23/93
 /CONTACT: R. Bruce Reeves, Ph.D., chief operating officer of Biorelease Corp., 603-893-7300; Marcia Kean or Chris Taylor, 617-577-8110, both of Feinstein Partners, for Biorelease/
 (BREL)


CO: Biorelease Corp. ST: New Hampshire IN: MTC SU: OFR

CH -- NE013 -- 8828 03/23/93 16:34 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 23, 1993
Words:239
Previous Article:BROADCASTING EXECUTIVE RICHARD L. GEISMAR NAMED DIRECTOR OF GUY GANNETT PUBLISHING CO.
Next Article:HEALTH-CHEM REPORTS RESULTS
Topics:


Related Articles
SYBRON FILES SHELF REGISTRATION STATEMENT
SYBRON FILES SHELF REGISTRATION STATEMENT
ARK SYSTEMS INC. FILES OFFERING TO SELL 650,000 UNITS AT $7.50 PER UNIT
CONTINUUM GROUP FILES FOR OFFERING
The Producers Entertainment Group Announces That Pacific Softworks Filed Registration Statement.
Conolog Announces Completion of Private Placement.
Raptor Pharmaceuticals Raises US$5 Million.
Raptor Pharmaceuticals Raises $5 Million.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters